Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Public Health Nutr ; 27(1): e123, 2024 Apr 19.
Article in English | MEDLINE | ID: mdl-38639113

ABSTRACT

OBJECTIVE: Most evidence supporting screening for undernutrition is for children aged 6-59 months. However, the highest risk of mortality and highest incidence of wasting occurs in the first 6 months of life. We evaluated relationships between neonatal anthropometric indicators, including birth weight, weight-for-age Z-score (WAZ), weight-for-length Z-score (WLZ), length-for-age Z-score (LAZ) and mid-upper arm circumference (MUAC) and mortality and growth at 6 months of age among infants in Burkina Faso. DESIGN: Data arose from a randomised controlled trial evaluating neonatal azithromycin administration for the prevention of child mortality. We evaluated relationships between baseline anthropometric measures and mortality, wasting (WLZ < -2), stunting (LAZ < -2) and underweight (WAZ < -2) at 6 months of age were estimated using logistic regression models adjusted for the child's age and sex. SETTING: Five regions of Burkina Faso. PARTICIPANTS: Infants aged 8-27 d followed until 6 months of age. RESULTS: Of 21 832 infants enrolled in the trial, 7·9 % were low birth weight (<2500 g), 13·3 % were wasted, 7·7 % were stunted and 7·4 % were underweight at enrolment. All anthropometric deficits were associated with mortality by 6 months of age, with WAZ the strongest predictor (WAZ < -2 to ≥ -3 at enrolment v. WAZ ≥ -2: adjusted OR, 3·91, 95 % CI, 2·21, 6·56). Low WAZ was also associated with wasting, stunting, and underweight at 6 months. CONCLUSIONS: Interventions for identifying infants at highest risk of mortality and growth failure should consider WAZ as part of their screening protocol.


Subject(s)
Anthropometry , Birth Weight , Growth Disorders , Infant Mortality , Thinness , Humans , Burkina Faso/epidemiology , Infant , Male , Female , Infant, Newborn , Growth Disorders/epidemiology , Growth Disorders/mortality , Thinness/epidemiology , Thinness/mortality , Body Height , Infant, Low Birth Weight , Azithromycin/administration & dosage , Azithromycin/therapeutic use , Child Development , Wasting Syndrome/epidemiology , Wasting Syndrome/mortality , Body Weight , Logistic Models
SELECTION OF CITATIONS
SEARCH DETAIL
...